148 related articles for article (PubMed ID: 21990984)
1. Ultrastructural differentiation of abnormal scars.
Meenakshi J; Jayaraman V; Ramakrishnan KM; Babu M
Ann Burns Fire Disasters; 2005 Jun; 18(2):83-8. PubMed ID: 21990984
[TBL] [Abstract][Full Text] [Related]
2. Hypertrophic and keloid scars fail to progress from the CD34
Limandjaja GC; Belien JM; Scheper RJ; Niessen FB; Gibbs S
Br J Dermatol; 2020 Apr; 182(4):974-986. PubMed ID: 31206605
[TBL] [Abstract][Full Text] [Related]
3. Endothelial dysfunction may play a key role in keloid and hypertrophic scar pathogenesis - Keloids and hypertrophic scars may be vascular disorders.
Ogawa R; Akaishi S
Med Hypotheses; 2016 Nov; 96():51-60. PubMed ID: 27959277
[TBL] [Abstract][Full Text] [Related]
4. Alterations in fibroblast alpha1beta1 integrin collagen receptor expression in keloids and hypertrophic scars.
Szulgit G; Rudolph R; Wandel A; Tenenhaus M; Panos R; Gardner H
J Invest Dermatol; 2002 Mar; 118(3):409-15. PubMed ID: 11874478
[TBL] [Abstract][Full Text] [Related]
5. Studies of transforming growth factors beta 1-3 and their receptors I and II in fibroblast of keloids and hypertrophic scars.
Bock O; Yu H; Zitron S; Bayat A; Ferguson MW; Mrowietz U
Acta Derm Venereol; 2005; 85(3):216-20. PubMed ID: 16040405
[TBL] [Abstract][Full Text] [Related]
6. Characterization of In Vitro Reconstructed Human Normotrophic, Hypertrophic, and Keloid Scar Models.
Limandjaja GC; van den Broek LJ; Breetveld M; Waaijman T; Monstrey S; de Boer EM; Scheper RJ; Niessen FB; Gibbs S
Tissue Eng Part C Methods; 2018 Apr; 24(4):242-253. PubMed ID: 29490604
[TBL] [Abstract][Full Text] [Related]
7. Increased epidermal thickness and abnormal epidermal differentiation in keloid scars.
Limandjaja GC; van den Broek LJ; Waaijman T; van Veen HA; Everts V; Monstrey S; Scheper RJ; Niessen FB; Gibbs S
Br J Dermatol; 2017 Jan; 176(1):116-126. PubMed ID: 27377288
[TBL] [Abstract][Full Text] [Related]
8. Keloid and Hypertrophic Scars Are the Result of Chronic Inflammation in the Reticular Dermis.
Ogawa R
Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28287424
[TBL] [Abstract][Full Text] [Related]
9. Endothelial cell-derived endothelin-1 is involved in abnormal scar formation by dermal fibroblasts through RhoA/Rho-kinase pathway.
Kiya K; Kubo T; Kawai K; Matsuzaki S; Maeda D; Fujiwara T; Nishibayashi A; Kanazawa S; Yano K; Amano G; Katayama T; Hosokawa K
Exp Dermatol; 2017 Aug; 26(8):705-712. PubMed ID: 27892645
[TBL] [Abstract][Full Text] [Related]
10. Vascularization pattern in hypertrophic scars and keloids: a stereological analysis.
Amadeu T; Braune A; Mandarim-de-Lacerda C; Porto LC; Desmoulière A; Costa A
Pathol Res Pract; 2003; 199(7):469-73. PubMed ID: 14521263
[TBL] [Abstract][Full Text] [Related]
11. Comparative ultrastructure of hypertrophic scars and keloids.
Kischer CW
Scan Electron Microsc; 1984; (Pt 1):423-31. PubMed ID: 6740239
[TBL] [Abstract][Full Text] [Related]
12. The Cellular Response of Keloids and Hypertrophic Scars to Botulinum Toxin A: A Comprehensive Literature Review.
Austin E; Koo E; Jagdeo J
Dermatol Surg; 2018 Feb; 44(2):149-157. PubMed ID: 29401161
[TBL] [Abstract][Full Text] [Related]
13. Effect of TGF-beta2 on proliferative scar fibroblast cell kinetics.
Polo M; Smith PD; Kim YJ; Wang X; Ko F; Robson MC
Ann Plast Surg; 1999 Aug; 43(2):185-90. PubMed ID: 10454327
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with different types of scars and keloids.
Ulrich D; Ulrich F; Unglaub F; Piatkowski A; Pallua N
J Plast Reconstr Aesthet Surg; 2010 Jun; 63(6):1015-21. PubMed ID: 19464975
[TBL] [Abstract][Full Text] [Related]
15. Fibronectin (FN) in hypertrophic scars and keloids.
Kischer CW; Hendrix MJ
Cell Tissue Res; 1983; 231(1):29-37. PubMed ID: 6342808
[TBL] [Abstract][Full Text] [Related]
16. Morphological and immunochemical differences between keloid and hypertrophic scar.
Ehrlich HP; Desmoulière A; Diegelmann RF; Cohen IK; Compton CC; Garner WL; Kapanci Y; Gabbiani G
Am J Pathol; 1994 Jul; 145(1):105-13. PubMed ID: 8030742
[TBL] [Abstract][Full Text] [Related]
17. Wnt Signaling Pathway Proteins in Scar, Hypertrophic Scar, and Keloid: Evidence for a Continuum?
Chaudet KM; Goyal A; Veprauskas KR; Nazarian RM
Am J Dermatopathol; 2020 Nov; 42(11):842-847. PubMed ID: 32310858
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical Evaluation of Leptin Expression in Wound Healing: A Clue to Exuberant Scar Formation.
Seleit I; Bakry OA; Samaka RM; Tawfik AS
Appl Immunohistochem Mol Morphol; 2016 Apr; 24(4):296-306. PubMed ID: 26258753
[TBL] [Abstract][Full Text] [Related]
19. Collagen biosynthesis in normal human skin, normal and hypertrophic scar and keloid.
Craig RD
Eur J Clin Invest; 1975 Feb; 5(1):69-74. PubMed ID: 1122925
[TBL] [Abstract][Full Text] [Related]
20. Reconstructed human keloid models show heterogeneity within keloid scars.
Limandjaja GC; van den Broek LJ; Waaijman T; Breetveld M; Monstrey S; Scheper RJ; Niessen FB; Gibbs S
Arch Dermatol Res; 2018 Dec; 310(10):815-826. PubMed ID: 30370495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
